vs
FIRST US BANCSHARES, INC.（FUSB）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是FIRST US BANCSHARES, INC.的1.2倍（$12.5M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -1398.3%，领先1418.8%），礼来同比增速更快（434.0% vs 7.1%），FIRST US BANCSHARES, INC.自由现金流更多（$9.1M vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs 2.6%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
FUSB vs RNA — 直观对比
营收规模更大
RNA
是对方的1.2倍
$10.4M
营收增速更快
RNA
高出427.0%
7.1%
净利率更高
FUSB
高出1418.8%
-1398.3%
自由现金流更多
FUSB
多$166.0M
$-156.9M
两年增速更快
RNA
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $12.5M |
| 净利润 | $2.1M | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | 28.1% | -1513.5% |
| 净利率 | 20.4% | -1398.3% |
| 营收同比 | 7.1% | 434.0% |
| 净利润同比 | 24.2% | -117.0% |
| 每股收益（稀释后） | $0.36 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBRNA
| Q4 25 | $10.4M | — | ||
| Q3 25 | $10.5M | $12.5M | ||
| Q2 25 | $10.3M | $3.8M | ||
| Q1 25 | $9.8M | $1.6M | ||
| Q4 24 | $9.7M | $3.0M | ||
| Q3 24 | $10.1M | $2.3M | ||
| Q2 24 | $10.0M | $2.0M | ||
| Q1 24 | $9.9M | $3.5M |
净利润FUSBRNA
| Q4 25 | $2.1M | — | ||
| Q3 25 | $1.9M | $-174.4M | ||
| Q2 25 | $155.0K | $-157.3M | ||
| Q1 25 | $1.8M | $-115.8M | ||
| Q4 24 | $1.7M | $-102.3M | ||
| Q3 24 | $2.2M | $-80.4M | ||
| Q2 24 | $2.1M | $-70.8M | ||
| Q1 24 | $2.1M | $-68.9M |
营业利润率FUSBRNA
| Q4 25 | 28.1% | — | ||
| Q3 25 | 23.9% | -1513.5% | ||
| Q2 25 | 1.6% | -4448.7% | ||
| Q1 25 | 23.8% | -8360.9% | ||
| Q4 24 | 23.8% | -4069.6% | ||
| Q3 24 | 29.2% | -4200.9% | ||
| Q2 24 | 27.4% | -4040.4% | ||
| Q1 24 | 27.8% | -2178.6% |
净利率FUSBRNA
| Q4 25 | 20.4% | — | ||
| Q3 25 | 18.4% | -1398.3% | ||
| Q2 25 | 1.5% | -4089.3% | ||
| Q1 25 | 18.1% | -7360.0% | ||
| Q4 24 | 17.6% | -3439.5% | ||
| Q3 24 | 22.0% | -3441.7% | ||
| Q2 24 | 21.2% | -3461.8% | ||
| Q1 24 | 21.3% | -1943.4% |
每股收益（稀释后）FUSBRNA
| Q4 25 | $0.36 | — | ||
| Q3 25 | $0.32 | $-1.27 | ||
| Q2 25 | $0.03 | $-1.21 | ||
| Q1 25 | $0.29 | $-0.90 | ||
| Q4 24 | $0.29 | $-0.80 | ||
| Q3 24 | $0.36 | $-0.65 | ||
| Q2 24 | $0.34 | $-0.65 | ||
| Q1 24 | $0.34 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $350.2M |
| 总债务越低越好 | $10.9M | — |
| 股东权益账面价值 | $105.6M | $1.9B |
| 总资产 | $1.2B | $2.1B |
| 负债/权益比越低杠杆越低 | 0.10× | — |
8季度趋势，按日历期对齐
现金及短期投资FUSBRNA
| Q4 25 | $73.5M | — | ||
| Q3 25 | $54.7M | $350.2M | ||
| Q2 25 | $54.0M | $243.9M | ||
| Q1 25 | $56.0M | $254.2M | ||
| Q4 24 | $47.2M | $219.9M | ||
| Q3 24 | $82.3M | $370.2M | ||
| Q2 24 | $58.2M | $575.8M | ||
| Q1 24 | $60.2M | $471.4M |
总债务FUSBRNA
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.9M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.9M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | — | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $10.8M | — |
股东权益FUSBRNA
| Q4 25 | $105.6M | — | ||
| Q3 25 | $104.2M | $1.9B | ||
| Q2 25 | $101.9M | $1.2B | ||
| Q1 25 | $101.2M | $1.3B | ||
| Q4 24 | $98.6M | $1.4B | ||
| Q3 24 | $98.5M | $1.5B | ||
| Q2 24 | $93.8M | $1.2B | ||
| Q1 24 | $92.3M | $830.9M |
总资产FUSBRNA
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $1.4B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.1B | $1.3B | ||
| Q1 24 | $1.1B | $951.5M |
负债/权益比FUSBRNA
| Q4 25 | 0.10× | — | ||
| Q3 25 | 0.10× | — | ||
| Q2 25 | 0.11× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.12× | — | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | $-156.9M |
| 自由现金流率自由现金流/营收 | 87.2% | -1257.6% |
| 资本支出强度资本支出/营收 | 31.1% | 5.7% |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | $-592.3M |
8季度趋势，按日历期对齐
经营现金流FUSBRNA
| Q4 25 | $12.3M | — | ||
| Q3 25 | $4.2M | $-156.2M | ||
| Q2 25 | $3.9M | $-199.7M | ||
| Q1 25 | $1.8M | $-124.8M | ||
| Q4 24 | $7.8M | $-99.9M | ||
| Q3 24 | $1.9M | $-65.6M | ||
| Q2 24 | $2.5M | $-65.0M | ||
| Q1 24 | $825.0K | $-70.4M |
自由现金流FUSBRNA
| Q4 25 | $9.1M | — | ||
| Q3 25 | $3.6M | $-156.9M | ||
| Q2 25 | $1.6M | $-203.0M | ||
| Q1 25 | $1.7M | $-128.6M | ||
| Q4 24 | $5.7M | $-103.8M | ||
| Q3 24 | $1.3M | $-67.3M | ||
| Q2 24 | $2.3M | $-65.5M | ||
| Q1 24 | $-142.0K | $-71.3M |
自由现金流率FUSBRNA
| Q4 25 | 87.2% | — | ||
| Q3 25 | 34.2% | -1257.6% | ||
| Q2 25 | 16.0% | -5277.1% | ||
| Q1 25 | 17.2% | -8174.3% | ||
| Q4 24 | 58.2% | -3491.0% | ||
| Q3 24 | 12.7% | -2881.8% | ||
| Q2 24 | 23.5% | -3204.6% | ||
| Q1 24 | -1.4% | -2012.3% |
资本支出强度FUSBRNA
| Q4 25 | 31.1% | — | ||
| Q3 25 | 5.9% | 5.7% | ||
| Q2 25 | 21.8% | 86.9% | ||
| Q1 25 | 0.7% | 238.6% | ||
| Q4 24 | 21.6% | 131.7% | ||
| Q3 24 | 6.6% | 72.9% | ||
| Q2 24 | 2.0% | 26.0% | ||
| Q1 24 | 9.8% | 25.8% |
现金转化率FUSBRNA
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
